Table 1.
Patient characteristics.
| Total (% of all applicable) | |
|---|---|
| Total | 41 |
| Median Age (IQR) at diagnosis [years] | 52 (15) |
| <50 years old | 17/41 (41) |
| ≥50 years old | 24/41 (59) |
| Menopausal Status | |
| Premenopausal | 8/41(20) |
| Perimenopausal | 8/41 (20) |
| Postmenopausal | 25/41 (60) |
| Histology | |
| Ductal | 30/39 (77) |
| Lobular | 1/39 (3) |
| Others | 8/39 (20) |
| Not known | 2/41 |
| Tumor Grading | |
| I | 0/41 (0) |
| II | 11/41 (27) |
| III | 30/41 (73) |
| Not known | 0/41 |
| Ki 67 | |
| 0–10% | 2/37 (5) |
| 11–30% | 4/37 (11) |
| >30% | 31/37 (84) |
| Not known | 4/41 |
| Tumor Size at First Diagnosis (c/T) | |
| T1a-c | 16/41 (39) |
| T2 | 22/41 (54) |
| T3 | 3/41 (7) |
| T4 | 0/41 (0) |
| Tumor Size After NACT (ypT) | |
| ypT0 | 17/39 (44) |
| ypT1 | 12/39 (31) |
| ypT2 | 9/39 (23) |
| ypT3-4 | 1/39 (3) |
| Not applicable | 2/41 |
| Nodal Status at First Diagnosis (c/pN) | |
| Node negative | 27/41 (66) |
| Node positive | 13/41 (32) |
| N1 | 10/41 (24) |
| N2 | 1/41 (2) |
| N3 | 3/41 (7) |
| Nodal Status After NACT (ypN) | |
| Node negative | 2/3 (66) |
| Node positive | 1/3 (33) |
| ypN1 | 0/3 (0) |
| ypN2 | 1/3 (33) |
| ypN3 | 0/3 (0) |
| Not applicable | 38/41 |
| Pathological Response | |
| Complete response | 18/39 (46) |
| Partial response | 18/39 (46) |
| No response | 3/39 (8) |
| Not applicable | 2/41 |
| Chemotherapy | |
| Yes | 41/41 (100) |
| Neoadjuvant | 39/41 (95) |
| Adjuvant | 2/41 (5) |